CEPH Message Board - Msg: 2710672

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ricardo A. Biondi who wrote (503)	11/12/1997 8:09:00 PM
From: virgil vancleave	Read Replies (1) of 998

it appears that most have left this company for dead and completely forgotten about their other drugs coming up for review. once and if they get provigal approved, investor sentiment may very well approve. and todays action was just bad everywhere. red on every attractive looking company i own or like. and myotropin is still alive. at 10 per share, this company is valued at just above cash per share level of 6. that is enough to go a few more years without any equity or debt financing which is of utmost importance in this industry. just happens that we are out of favor here. patient investors will hopefully be rewarded. good luck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next